Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Design Therapeutics (DSGN) Amortization of Deferred Charges (2020)

Design Therapeutics' Amortization of Deferred Charges history spans 1 years, with the latest figure at $12000.0 for Q1 2020.

  • For Q1 2020, Amortization of Deferred Charges changed N/A year-over-year to $12000.0; the TTM value through Dec 2020 reached $12000.0, changed N/A, while the annual FY2020 figure was $12000.0, N/A changed from the prior year.
  • Amortization of Deferred Charges for Q1 2020 was $12000.0 at Design Therapeutics.
  • Across five years, Amortization of Deferred Charges topped out at $12000.0 in Q1 2020 and bottomed at $12000.0 in Q1 2020.